Characterization of siglec-5, a novel glycoprotein expressed on myeloid cells related to CD33.
about
Identification and molecular cloning of p75/AIRM1, a novel member of the sialoadhesin family that functions as an inhibitory receptor in human natural killer cellsIdentification, characterization and leucocyte expression of Siglec-10, a novel human sialic acid-binding receptorStructural implications of Siglec-5-mediated sialoglycan recognitionSiglecs in the immune systemSIGLEC12, a human-specific segregating (pseudo)gene, encodes a signaling molecule expressed in prostate carcinomasmSiglec-E, a novel mouse CD33-related siglec (sialic acid-binding immunoglobulin-like lectin) that recruits Src homology 2 (SH2)-domain-containing protein tyrosine phosphatases SHP-1 and SHP-2Multivalent Interactions of Human Primary Amine Oxidase with the V and C22 Domains of Sialic Acid-Binding Immunoglobulin-Like Lectin-9 Regulate Its Binding and Amine Oxidase ActivityAdipose tissue deficiency and chronic inflammation in diabetic Goto-Kakizaki ratsSoluble Siglec-5 associates to PSGL-1 and displays anti-inflammatory activity.Targeting GPVI as a novel antithrombotic strategy.Relative over-reactivity of human versus chimpanzee lymphocytes: implications for the human diseases associated with immune activation.Dectin-1 is essential for reverse transcytosis of glycosylated SIgA-antigen complexes by intestinal M cellsCD33/Siglec-3 binding specificity, expression pattern, and consequences of gene deletion in miceDifferences in the constitutive and SIV infection induced expression of Siglecs by hematopoietic cells from non-human primates.Basic and clinical immunology of SiglecsTargeting Notch-1 positive acute leukemia cells by novel fucose-bound liposomes carrying daunorubicin.Developing aptamer probes for acute myelogenous leukemia detection and surface protein biomarker discovery.Sialic acids siglec interaction: a unique strategy to circumvent innate immune response by pathogens.Host Immune Responses in HIV-1 Infection: The Emerging Pathogenic Role of Siglecs and Their Clinical Correlates.Evolution of CD33-related siglecs: regulating host immune functions and escaping pathogen exploitation?Molecular analysis of sialoside binding to sialoadhesin by NMR and site-directed mutagenesis.Human Siglec-5 inhibitory receptor and immunoglobulin A (IgA) have separate binding sites in streptococcal beta protein.Sialic Acid Is Required for Neuronal Inhibition by Soluble MAG but not for Membrane Bound MAG.Studies on the Detection, Expression, Glycosylation, Dimerization, and Ligand Binding Properties of Mouse Siglec-E.Cytokine-induced killer cells for cell therapy of acute myeloid leukemia: improvement of their immune activity by expression of CD33-specific chimeric receptors.Glycobiology of Eosinophilic Inflammation: Contributions of Siglecs, Glycans, and Other Glycan-Binding Proteins.Factor VIII and von Willebrand factor are ligands for the carbohydrate-receptor Siglec-5.Streptococcus agalactiae Non-Pilus, Cell Wall-Anchored Proteins: Involvement in Colonization and Pathogenesis and Potential as Vaccine Candidates.
P2860
Q22010576-CD022D15-567E-4DC9-AF63-551A7C2393F9Q24532754-67D0AF33-5C07-4991-A72E-C8C5974AD590Q24646384-C70B24E0-BEB3-4F86-B992-0473DEB1530AQ24682458-54A8129B-F0A9-4BFF-801B-25E196FCE216Q28237131-F0063FF0-04F6-4262-B281-03A7A06E1051Q28347604-35E67E0C-8229-4CF0-8991-93AF84A48AD1Q28554453-7A94CE0F-8B44-46AB-9F83-0E61CC0E93C0Q28742364-5936B6B2-0AD0-4471-86DA-B323BEF896C1Q30829904-E213D60A-6C2D-4495-92EC-52952C187815Q33689745-58D8CD91-7D3C-437E-AAC8-2080957F18D3Q34903504-C86222FB-7D64-4AC2-A0DF-3F10C181EFB2Q34998132-2A136317-45A9-4521-888B-7FF2C51F89EDQ35019914-8A8BBEC7-8D86-4280-8453-A920F1A3F863Q36691835-344EA9E3-A37F-49ED-B193-9E2DD8179ADAQ37348437-6962931E-CC74-4DC9-A90F-5D0E59CA385FQ37437588-7F9AE317-0626-455B-9CD7-43622199236EQ37493869-BD99DAE6-3837-4414-8741-33B3E541ACB8Q37592363-E11ABEB1-D12E-4A34-BDCC-172C6FA5E6D1Q37716750-EF8630DB-3072-4767-8BBB-EF045464BCEEQ37808728-F6E95575-AD23-4071-9ACE-FF0253367F82Q38323182-8C58E4E0-BB72-43E3-ABA4-44825CB41D83Q38674244-2BB18F11-7A27-4C62-BE92-292E498A8EB5Q38804733-1CD57915-1ED5-4C82-8C5B-2B0E05F11553Q39128543-9D374EB4-1DD0-4C05-A096-CB059154A4DFQ39667028-D38759CD-25ED-4607-8BF7-CD5819A796EFQ41207923-1D99E837-A163-4AC2-89AC-591E9619BDECQ42133647-CD3B76A5-30EC-4A3B-8BF3-9A249D847947Q52568338-B754CC6D-EBDC-49CF-8BCB-C45EAFAD3C70
P2860
Characterization of siglec-5, a novel glycoprotein expressed on myeloid cells related to CD33.
description
1998 nî lūn-bûn
@nan
1998 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Characterization of siglec-5, ...... myeloid cells related to CD33.
@ast
Characterization of siglec-5, ...... myeloid cells related to CD33.
@en
type
label
Characterization of siglec-5, ...... myeloid cells related to CD33.
@ast
Characterization of siglec-5, ...... myeloid cells related to CD33.
@en
prefLabel
Characterization of siglec-5, ...... myeloid cells related to CD33.
@ast
Characterization of siglec-5, ...... myeloid cells related to CD33.
@en
P2093
P1433
P1476
Characterization of siglec-5, ...... myeloid cells related to CD33
@en
P2093
Augustus M
Cornish AL
Crocker PR
P304
P407
P577
1998-09-01T00:00:00Z